Baseline demographics and lumber spine BMC and BMD measurements
. | ALN; N = 17 . | Placebo; N = 17 . | P . |
|---|---|---|---|
| Baseline | |||
| Male sex, % | 29 | 29 | |
| Age, y | 39.50 ± 7.38 | 32.99 ± 9.91 | .0374 |
| Enzyme dose, | |||
| U/kg | 28.88 ± 8.66 | 37.59 ± 15.09 | .049 |
| BMC, g | 59.13 ± 15.60 | 60.62 ± 13.92 | .7707 |
| BMD, g/cm2 | 0.95 ± 0.14 | 0.95 ± 0.14 | .9527 |
. | ALN; N = 17 . | Placebo; N = 17 . | P . |
|---|---|---|---|
| Baseline | |||
| Male sex, % | 29 | 29 | |
| Age, y | 39.50 ± 7.38 | 32.99 ± 9.91 | .0374 |
| Enzyme dose, | |||
| U/kg | 28.88 ± 8.66 | 37.59 ± 15.09 | .049 |
| BMC, g | 59.13 ± 15.60 | 60.62 ± 13.92 | .7707 |
| BMD, g/cm2 | 0.95 ± 0.14 | 0.95 ± 0.14 | .9527 |
Values for ALN and placebo represent the mean ± the standard error of the mean.